Literature DB >> 21541442

Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.

Monica Colombo1, Giovanna Cutrona, Daniele Reverberi, Sonia Fabris, Antonino Neri, Marina Fabbi, Giovanni Quintana, Giovanni Quarta, Fabio Ghiotto, Franco Fais, Manlio Ferrarini.   

Abstract

The mutational status of the immunoglobulin heavy-chain variable region (IGHV) genes utilized by chronic lymphocytic leukemia (CLL) clones defines two disease subgroups. Patients with unmutated IGHV have a more aggressive disease and a worse outcome than patients with cells having somatic IGHV gene mutations. Moreover, up to 30% of the unmutated CLL clones exhibit very similar or identical B cell receptors (BcR), often encoded by the same IG genes. These "stereotyped" BcRs have been classified into defined subsets. The presence of an IGHV gene somatic mutation and the utilization of a skewed gene repertoire compared with normal B cells together with the expression of stereotyped receptors by unmutated CLL clones may indicate stimulation/selection by antigenic epitopes. This antigenic stimulation may occur prior to or during neoplastic transformation, but it is unknown whether this stimulation/selection continues after leukemogenesis has ceased. In this study, we focused on seven CLL cases with stereotyped BcR Subset #8 found among a cohort of 700 patients; in six, the cells expressed IgG and utilized IGHV4-39 and IGKV1-39/IGKV1D-39 genes, as reported for Subset #8 BcR. One case exhibited special features, including expression of IgM or IgG by different subclones consequent to an isotype switch, allelic inclusion at the IGH locus in the IgM-expressing cells and a particular pattern of cytogenetic lesions. Collectively, the data indicate a process of antigenic stimulation/selection of the fully transformed CLL cells leading to the expansion of the Subset #8 IgG-bearing subclone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21541442      PMCID: PMC3146619          DOI: 10.2119/molmed.2011.00047

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  36 in total

Review 1.  Chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi; Kanti R Rai; Manlio Ferrarini
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

2.  Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.

Authors:  Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

3.  IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukaemia.

Authors:  Davide Bagnara; Vincenzo Callea; Caterina Stelitano; Fortunato Morabito; Sonia Fabris; Antonino Neri; Sabrina Zanardi; Fabio Ghiotto; Ermanno Ciccone; Carlo Enrico Grossi; Franco Fais
Journal:  Br J Haematol       Date:  2006-04       Impact factor: 6.998

4.  Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins.

Authors:  Anastasia Athanasiadou; Kostas Stamatopoulos; Maria Gaitatzi; Niki Stavroyianni; Athanasios Fassas; Achilles Anagnostopoulos
Journal:  Haematologica       Date:  2008-03       Impact factor: 9.941

5.  Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.

Authors:  Maxime Hervé; Kai Xu; Yen-Shing Ng; Hedda Wardemann; Emilia Albesiano; Bradley T Messmer; Nicholas Chiorazzi; Eric Meffre
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

6.  Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

Authors:  Kostas Stamatopoulos; Chrysoula Belessi; Carol Moreno; Myriam Boudjograh; Giuseppe Guida; Tatjana Smilevska; Lynda Belhoul; Stefania Stella; Niki Stavroyianni; Marta Crespo; Anastasia Hadzidimitriou; Laurent Sutton; Francesc Bosch; Nikolaos Laoutaris; Achilles Anagnostopoulos; Emili Montserrat; Athanasios Fassas; Guillaume Dighiero; Federico Caligaris-Cappio; Hélène Merle-Béral; Paolo Ghia; Frédéric Davi
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

7.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.

Authors:  Giovanna Cutrona; Monica Colombo; Serena Matis; Marina Fabbi; Mauro Spriano; Vincenzo Callea; Ernesto Vigna; Massimo Gentile; Simonetta Zupo; Nicholas Chiorazzi; Fortunato Morabito; Manlio Ferrarini
Journal:  Haematologica       Date:  2008-02-20       Impact factor: 9.941

9.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

Authors:  Fiona Murray; Nikos Darzentas; Anastasia Hadzidimitriou; Gerard Tobin; Myriam Boudjogra; Cristina Scielzo; Nikolaos Laoutaris; Karin Karlsson; Fanny Baran-Marzsak; Athanasios Tsaftaris; Carol Moreno; Achilles Anagnostopoulos; Federico Caligaris-Cappio; Dominique Vaur; Christos Ouzounis; Chrysoula Belessi; Paolo Ghia; Fred Davi; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

Review 10.  Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells.

Authors:  Nicholas Chiorazzi
Journal:  Best Pract Res Clin Haematol       Date:  2007-09       Impact factor: 3.020

View more
  1 in total

1.  Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence.

Authors:  Lesley-Ann Sutton; Efterpi Kostareli; Evangelia Stalika; Athanasios Tsaftaris; Achilles Anagnostopoulos; Nikos Darzentas; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Mol Med       Date:  2013-08-28       Impact factor: 6.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.